Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €75.00 by Nord/LB

Nord/LB set a €75.00 ($88.24) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report released on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Several other research firms also recently issued reports on FME. Jefferies Financial Group set a €60.00 ($70.59) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a sell rating in a report on Thursday, May 6th. The Goldman Sachs Group set a €69.00 ($81.18) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Thursday, May 6th. Independent Research set a €71.00 ($83.53) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Thursday, February 25th. UBS Group set a €74.00 ($87.06) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Thursday, May 6th. Finally, Berenberg Bank set a €79.50 ($93.53) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Thursday, May 6th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of €69.66 ($81.96).

FME opened at €67.14 ($78.99) on Wednesday. The company has a quick ratio of 0.69, a current ratio of 1.08 and a debt-to-equity ratio of 97.74. The company has a market cap of $19.66 billion and a price-to-earnings ratio of 17.39. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €55.18 ($64.92) and a 52-week high of €79.96 ($94.07). The firm’s fifty day simple moving average is €64.26 and its two-hundred day simple moving average is €65.41.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also: How to use beta for portfolio diversification

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.